0001104659-20-124026.txt : 20201112 0001104659-20-124026.hdr.sgml : 20201112 20201112084556 ACCESSION NUMBER: 0001104659-20-124026 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201109 FILED AS OF DATE: 20201112 DATE AS OF CHANGE: 20201112 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Walker Karin L CENTRAL INDEX KEY: 0001559422 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-50626 FILM NUMBER: 201303736 MAIL ADDRESS: STREET 1: C/O PROTHENA CORPORATION PLC STREET 2: 650 GATEWAY BOULEVARD CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cyclacel Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001130166 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 911766850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 BUSINESS PHONE: 908-517-7330 MAIL ADDRESS: STREET 1: 200 CONNELL DRIVE STREET 2: SUITE 1500 CITY: BERKELEY HEIGHTS STATE: NJ ZIP: 07922 FORMER COMPANY: FORMER CONFORMED NAME: XCYTE THERAPIES INC DATE OF NAME CHANGE: 20001218 4 1 tm2035660d2_4.xml OWNERSHIP DOCUMENT X0306 4 2020-11-09 0 0001130166 Cyclacel Pharmaceuticals, Inc. CYCC 0001559422 Walker Karin L C/O CYCLACEL PHARMACEUTICALS, INC., 200 CONNELL DRIVE, SUITE 1500 BERKELEY HEIGHTS NJ 07922 1 0 0 0 Stock Option (right to buy) 3.33 2020-11-09 4 A 0 5200 0 A 2021-11-09 2030-11-09 Common Stock 5200 5200 D These options were granted to Ms. Walker for her services as a member of the board of directors of Cyclacel Pharmaceuticals, Inc. /s/ Karin L. Walker 2020-11-12